24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
When and How to Use Therapeutic Drug Monitoring in IBD Patients Bruce E. Sands, MD, MS Chief of the Dr. Henry D. Janowitz Division of Gastroenterology.
Protein Therapeutics Immunogenicity Stephen Lynn 11-16-11 CHEM645 0.
Strategic and scientific approaches to developing bioassays to support biologics Darren Kamikura, Ph.D. Bioassay Development Eli Lilly and Company Indianapolis,
